Mesosil develops bioactive materials with antimicrobial technology specifically designed for dental restoratives and implant surfaces. This technology reduces the risk of infection and enhances the longevity of dental and medical devices.
Funding
$2.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Dental restoratives and implant surfaces are susceptible to microbial colonization, leading to infections, implant failures, and reduced longevity of dental devices. Current antimicrobial solutions often lack long-term efficacy or can have adverse effects on surrounding tissues.
Solution
Mesosil develops bioactive materials incorporating antimicrobial technology designed to mitigate infection risks and improve the durability of dental restoratives and implant surfaces. Their materials are engineered to provide sustained antimicrobial activity, preventing biofilm formation and promoting a healthier oral environment. By integrating this technology into dental materials, Mesosil aims to enhance the success rates of dental procedures and extend the lifespan of dental implants and restorations.
Target Audience
Mesosil's primary customers are dental material manufacturers, dental implant companies, and dental professionals seeking to improve the performance and longevity of their products and procedures.
Features
- Bioactive materials with sustained antimicrobial properties
- Prevents biofilm formation on dental restoratives and implant surfaces
- Enhances the longevity of dental implants and restorations
- Reduces the risk of infection associated with dental procedures